Professor Rebecca Helen Ritchie

Professor Rebecca Helen Ritchie

Monash University, Melbourne (Australia)

Member of:

Professor Ritchie [FISHR, FCSANZ; FAHA] is Professor and Head of Drug Discovery Biology (Theme Leader) and Head of Heart Failure Pharmacology in the Monash Institute of Pharmaceutical Sciences (MIPS), Monash University. She completed her PhD studies at the University of Adelaide in 1994 - her career spans discovery, preclinical & clinical research, enabled by long-term collaborations across Monash, the Victorian Heart Institute & the Baker Heart & Diabetes Institute. Prof Ritchie is a cardiac pharmacologist internationally-recognised for her translational research focused on arresting the progression of heart failure. Her work focuses on 3 major types of heart failure: diabetes-associated heart failure; heart failure after myocardial infarction; and HFpEF- seeking to identify optimal treatments for these, and whether there are sex-specific differences. This is particularly important as women are more susceptible to diabetes-associated & HFpEF forms of heart failure.